Retractable Technologies (NYSE:RVP) Receives New Coverage from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a note issued to investors on Monday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.94 on Monday. The business has a 50 day moving average price of $1.09 and a 200 day moving average price of $1.14. The company has a debt-to-equity ratio of 0.01, a current ratio of 11.02 and a quick ratio of 8.18. The company has a market capitalization of $28.16 million, a P/E ratio of -3.62 and a beta of 2.11. Retractable Technologies has a 1-year low of $0.87 and a 1-year high of $1.34.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%. The business had revenue of $7.60 million during the quarter.

Insider Buying and Selling

In related news, CEO Thomas J. Shaw purchased 48,635 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was bought at an average price of $1.03 per share, with a total value of $50,094.05. Following the completion of the transaction, the chief executive officer now owns 14,417,148 shares of the company’s stock, valued at approximately $14,849,662.44. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders purchased 129,367 shares of company stock worth $135,644 in the last ninety days. Insiders own 55.00% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.